{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:21:08Z","timestamp":1792653668594,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.healun.2005.06.027","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T15:58:28Z","timestamp":1126108708000},"page":"2114-2119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Intravenous Ribavirin Is a Safe and Cost-effective Treatment for Respiratory Syncytial Virus Infection After Lung Transplantation"],"prefix":"10.1016","volume":"24","author":[{"given":"Allan R.","family":"Glanville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew I.R.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Aboyoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall L.","family":"Plit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian W.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique A.","family":"Malouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2005.06.027_bib1","first-page":"479","article-title":"Paramyxovirus infection in lung transplant recipients","volume":"14","author":"Wendt","year":"1995","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 1","key":"10.1016\/j.healun.2005.06.027_bib2","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/320906","article-title":"Epidemiology and management of infections after lung transplantation","volume":"33","author":"Speich","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2005.06.027_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.bmt.1703365","article-title":"Respiratory syncytial virus infection following hematopoietic stem cell transplantation","volume":"29","author":"Small","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.healun.2005.06.027_bib4","first-page":"202","article-title":"Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants","volume":"17","author":"Krinzman","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.06.027_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.113.4.944","article-title":"Community respiratory viral infection in adult lung transplant recipients","volume":"113","author":"Palmer","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.healun.2005.06.027_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiology.213.3.r99dc25735","article-title":"Respiratory viral infections in lung transplant recipients","volume":"213","author":"Matar","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.healun.2005.06.027_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1053-2498(02)00467-9","article-title":"Indirect fluorescent antibody testing of nasopharyngeal swabs for influenza diagnosis in lung transplant recipients","volume":"22","author":"Hopkins","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.06.027_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/CMR.13.3.371","article-title":"Respiratory syncytial virus infection in adults","volume":"13","author":"Falsey","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.healun.2005.06.027_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.12.2.298","article-title":"Respiratory syncytial virus infection","volume":"12","author":"Domachowske","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.healun.2005.06.027_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004728-200003000-00009","article-title":"CT manifestations of respiratory syncytial virus infection in lung transplant recipients","volume":"24","author":"Ko","year":"2000","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.healun.2005.06.027_bib11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.bmt.1700752","article-title":"Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections","volume":"19","author":"Sparrelid","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.healun.2005.06.027_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00001432-200106000-00013","article-title":"Management of respiratory syncytial virus infection","volume":"14","author":"Kimpen","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.healun.2005.06.027_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/viro.2002.1487","article-title":"Quasispecies, error catastrophe, and the antiviral activity of ribavirin","volume":"298","author":"Graci","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.healun.2005.06.027_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.healun.2005.06.027_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/AAC.45.4.1231-1237.2001","article-title":"Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro","volume":"45","author":"Gower","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.healun.2005.06.027_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1053-2498(02)00398-4","article-title":"Bronchiolitis obliterans syndrome 2001","volume":"21","author":"Estenne","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.06.027_bib17","series-title":"Report on the Bartels Viral Respiratory Screening and Identification Kit. Publication 3450-0185E","year":"1995"},{"key":"10.1016\/j.healun.2005.06.027_bib18","series-title":"Manual of clinical microbiology","first-page":"687","author":"Lennette","year":"1995"},{"key":"10.1016\/j.healun.2005.06.027_bib19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.healun.2003.08.008","article-title":"Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation","volume":"23","author":"Morton","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.06.027_bib20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2003.08.032","article-title":"Cyclosporine C2 monitoring improves renal dysfunction after lung transplantation","volume":"23","author":"Glanville","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.06.027_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1164\/rccm.200310-1359OC","article-title":"Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death","volume":"170","author":"Khalifah","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2005.06.027_bib22","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/rccm.200406-781OC","article-title":"Lower respiratory viral illnesses","volume":"170","author":"Garbino","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2005.06.027_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-5223(19)35800-3","article-title":"Steroid-responsive bronchiolitis after human heart\u2013lung transplantation","volume":"92","author":"Allen","year":"1986","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2005.06.027_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1053-2498(02)00569-7","article-title":"Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin","volume":"22","author":"McCurdy","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.06.027_bib25","first-page":"77","article-title":"Respiratory syncytial virus pneumonia in a lung transplant recipient","volume":"11","author":"Doud","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.06.027_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0140-6736(93)93106-B","article-title":"Continuous aerosolised tribavirin for respiratory syncytial virus infection in lung transplant recipients","volume":"341","author":"Murris-Espin","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2005.06.027_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.thj.6200358","article-title":"Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and\/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants","volume":"5","author":"Schleuning","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.healun.2005.06.027_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1034\/j.1399-3062.2001.003003138.x","article-title":"Community respiratory virus infections following lung transplantation","volume":"3","author":"Billings","year":"2001","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.healun.2005.06.027_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/003655401750173869","article-title":"Management of infections caused by respiratory syncytial virus","volume":"33","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.healun.2005.06.027_bib30","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1128\/AAC.40.11.2555","article-title":"Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation","volume":"40","author":"Lewinsohn","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.healun.2005.06.027_bib31","first-page":"CD000181","article-title":"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract","author":"Randolph","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.healun.2005.06.027_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/cimm.2001.1869","article-title":"Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone","volume":"213","author":"Bonville","year":"2001","journal-title":"Cell Immunol"},{"key":"10.1016\/j.healun.2005.06.027_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.healun.2004.01.003","article-title":"Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone","volume":"24","author":"Wright","year":"2005","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249805004420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249805004420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:12:32Z","timestamp":1760947952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249805004420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1053249805004420"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2005.06.027","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Ribavirin Is a Safe and Cost-effective Treatment for Respiratory Syncytial Virus Infection After Lung Transplantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2005.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}